Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing

NCT01324895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 944

Last updated 2012-03-26

No results posted yet for this study

Summary

The objective of this study is to compare the efficacy of prokinetics versus antibiotics versus a combination of antibiotics plus prokinetics in the eradication of Small-Intestinal Bacterial Over-Growth Syndrome (SIBO) in those with and without a positive D-xylose Breath Test.

Hypothesis: Patients with SIBO treated with a combination of prokinetics and in particular octreotide and antibiotics will have reduced recurrence rates of SIBO than either therapy given alone.

Conditions

  • Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
  • Small Bowel Bacterial Overgrowth Syndrome (SBBOS)

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Baharak Moshiree, MD, MS · University of Florida

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01324895 on ClinicalTrials.gov